Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:35 PM
Ignite Modification Date:
2025-12-24 @ 12:35 PM
NCT ID:
NCT00963261
Eligibility Criteria:
Inclusion Criteria:
* Documented and proven stage Ib up to stage IIIc malignant melanoma
* No clinical and radiological evidence or suspicion of persistent disease
* Treatment with IFN-α within a study or analog treatment schedule with IFN-α
* ECOG performance status \< 2
* Constant after care
* Informed consent to participate in the study
* melanoma diagnosis within the last 5 years or therapy, recurrence or progression within this period of time.
Exclusion Criteria:
* Inoperable lymph nodes- or distant metastases
* Tumors of other origins or localisations within the past 10 years
* Severe and permanent infectious diseases, e. g. HIV or hepatitis
* Participation in other treatment studies apart from IFN-α
* Insufficient knowledge of German language
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00963261
Study Brief:
Protocol Section:
NCT00963261